Tau(Phospho Ser404) Polyclonal Antibody

This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.

Introducing the TAU(PHOSPHO SER404) Polyclonal Antibody, a highly specific and sensitive tool for the detection and quantification of TAU protein phosphorylated at serine 404. This antibody has been rigorously tested and validated for use in a variety of applications, including western blotting, immunohistochemistry, and immunofluorescence.

The TAU(PHOSPHO SER404) Polyclonal Antibody is produced using state-of-the-art techniques and high-quality materials, ensuring exceptional performance and reproducibility. It exhibits minimal cross-reactivity with non-phosphorylated TAU protein, making it an ideal choice for studying the phosphorylation status of TAU in various biological samples.

This antibody is supplied in a convenient format, with ample quantity for multiple experiments. It is also accompanied by comprehensive technical support, including detailed protocols and troubleshooting advice, to ensure successful results.

In summary, the TAU(PHOSPHO SER404) Polyclonal Antibody is a reliable and effective tool for investigating the role of TAU phosphorylation in various physiological and pathological processes. Its high specificity and sensitivity make it an essential reagent for researchers in the fields of neuroscience, cell biology, and molecular biology.